肝硬化门静脉高压的无创筛查管理

张晓丰; 陈金军

doi:10.3969/j.issn.1001-5256.2022.06.002

肝硬化门静脉高压的无创筛查管理

DOI: 10.3969/j.issn.1001-5256.2022.06.002

张晓丰^{1, 2},
陈金军^{1, 2, 3, , ,}

1.
南方医科大学南方医院肝病中心，广州 510515
2.
南方医科大学南方医院增城分院肝病科，广州 511300
3.
广东省肝脏疾病研究所，广州 510515

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：张晓丰负责查找文献，撰写文稿；陈金军负责确定写作思路，指导文章撰写及最后定稿。

详细信息

通信作者:
陈金军，chjj@smu.edu.cn

计量
- 文章访问数: 825
- HTML全文浏览量: 155
- PDF下载量: 166
- 被引次数: 0
出版历程
- 收稿日期: 2022-03-06
- 录用日期: 2022-04-12
- 出版日期: 2022-06-20

Noninvasive screening and management of cirrhotic portal hypertension

Xiaofeng ZHANG^{1, 2},
Jinjun CHEN^{1, 2, 3
, ,
,}

1.
Hepatology Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2.
Department of Hepatology, Zengcheng Branch of Nanfang Hospital, Southern Medical University, Guangzhou 511300, China
3.
Hepatology Institute of Guangdong Province, Guangzhou 510515, China

More Information

Corresponding author: CHEN Jinjun, chjj@smu.edu.cn (ORCID: 0000-0003-4275-9149)

摘要

摘要: 门静脉高压相关并发症是进展期慢性肝病(ACLD)患者死亡的主要原因。肝静脉压力梯度为评估门静脉高压的金标准，上消化道内镜检查是筛查和评估食管胃静脉曲张及严重程度的重要手段；两者均为侵入性操作，不便于门静脉高压的筛查和监测。瞬时弹性成像、声辐射力脉冲弹性成像、剪切波弹性成像等无创方式，可用于ACLD患者门静脉高压，尤其是临床显著性门静脉高压的筛查、分层诊断和监测。
- 肝硬化 /
- 高血压, 门静脉 /
- 弹性成像技术
Abstract: Portal hypertension-related complications are the major cause of death in patients with advanced chronic liver disease (ACLD). Hepatic venous pressure gradient is the golden standard for assessing portal hypertension, and upper gastrointestinal endoscopy is an important method for screening and assessing esophageal and gastric varices and its severity; both methods are invasive and inappropriate for portal hypertension screening and monitoring. Noninvasive approaches, such as transient elastography, acoustic radiation force impulse, and shear wave elastography, have been used for the evaluation of portal hypertension in ACLD patients, especially the screening, stratified diagnosis, and monitoring of clinically significant portal hypertension.
- Liver Cirrhosis /
- Hypertension, Portal /
- Elasticity Imaging Techniques

HTML全文

参考文献(35)

[1]	de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
[2]	D'AMICO G, PASTA L, MORABITO A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients[J]. Aliment Pharmacol Ther, 2014, 39(10): 1180-1193. DOI: 10.1111/apt.12721.
[3]	D'AMICO G, GARCIA-TSAO G, PAGLIARO L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies[J]. J Hepatol, 2006, 44(1): 217-231. DOI: 10.1016/j.jhep.2005.10.013.
[4]	RIPOLL C, GROSZMANN R, GARCIA-TSAO G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis[J]. Gastroenterology, 2007, 133(2): 481-488. DOI: 10.1053/j.gastro.2007.05.024.
[5]	de FRANCHIS R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno Ⅵ Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752. DOI: 10.1016/j.jhep.2015.05.022.
[6]	PAPATHEODORIDI M, HIRIART JB, LUPSOR-PLATON M, et al. Refining the Baveno Ⅵ elastography criteria for the definition of compensated advanced chronic liver disease[J]. J Hepatol, 2021, 74(5): 1109-1116. DOI: 10.1016/j.jhep.2020.11.050.
[7]	JI Y, LI J, HE Q, et al. Baveno Ⅵ elastography criteria for ruling in cACLD works well in MAFLD patients[J]. J Hepatol, 2021, 75(5): 1243-1245. DOI: 10.1016/j.jhep.2021.06.003.
[8]	ZHOU YJ, GAO F, LIU WY, et al. Screening for compensated advanced chronic liver disease using refined Baveno Ⅵ elastography cutoffs in Asian patients with nonalcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2021, 54(4): 470-480. DOI: 10.1111/apt.16487.
[9]	VIZZUTTI F, ARENA U, ROMANELLI RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis[J]. Hepatology, 2007, 45(5): 1290-1297. DOI: 10.1002/hep.21665.
[10]	SHI KQ, FAN YC, PAN ZZ, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease[J]. Liver Int, 2013, 33(1): 62-71. DOI: 10.1111/liv.12003.
[11]	REIBERGER T, FERLITSCH A, PAYER BA, et al. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis[J]. J Gastroenterol, 2012, 47(5): 561-568. DOI: 10.1007/s00535-011-0517-4.
[12]	PONS M, AUGUSTIN S, SCHEINER B, et al. Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease[J]. Am J Gastroenterol, 2021, 116(4): 723-732. DOI: 10.14309/ajg.0000000000000994.
[13]	KIM BK, HAN KH, PARK JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis[J]. Am J Gastroenterol, 2010, 105(6): 1382-1390. DOI: 10.1038/ajg.2009.750.
[14]	ABRALDES JG, BUREAU C, STEFANESCU H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate"study[J]. Hepatology, 2016, 64(6): 2173-2184. DOI: 10.1002/hep.28824.
[15]	STAFYLIDOU M, PASCHOS P, KATSOULA A, et al. Performance of Baveno Ⅵ and expanded Baveno Ⅵ criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and Meta-analysis[J]. Clin Gastroenterol Hepatol, 2019, 17(9): 1744-1755. e11. DOI: 10.1016/j.cgh.2019.04.062.
[16]	WANG H, WEN B, CHANG X, et al. Baveno Ⅵ criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis[J]. J Hepatol, 2021, 74(3): 584-592. DOI: 10.1016/j.jhep.2020.09.034.
[17]	THABUT D, BUREAU C, LAYESE R, et al. Validation of Baveno Ⅵ criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy[J]. Gastroenterology, 2019, 156(4): 997-1009. e5. DOI: 10.1053/j.gastro.2018.11.053.
[18]	DING NS, NGUYEN T, ISER DM, et al. Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices[J]. Liver Int, 2016, 36(2): 240-245. DOI: 10.1111/liv.12916.
[19]	STEFANESCU H, GRIGORESCU M, LUPSOR M, et al. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients[J]. J Gastroenterol Hepatol, 2011, 26(1): 164-170. DOI: 10.1111/j.1440-1746.2010.06325.x.
[20]	COLECCHIA A, RAVAIOLI F, MARASCO G, et al. A combined model based on spleen stiffness measurement and Baveno Ⅵ criteria to rule out high-risk varices in advanced chronic liver disease[J]. J Hepatol, 2018, 69(2): 308-317. DOI: 10.1016/j.jhep.2018.04.023.
[21]	ROBIC MA, PROCOPET B, MÉTIVIER S, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study[J]. J Hepatol, 2011, 55(5): 1017-1024. DOI: 10.1016/j.jhep.2011.01.051.
[22]	LEE HW, YIP TC, TSE YK, et al. Hepatic decompensation in cirrhotic patients receiving antiviral therapy for chronic hepatitis B[J]. Clin Gastroenterol Hepatol, 2021, 19(9): 1950-1958. e7. DOI: 10.1016/j.cgh.2020.08.064.
[23]	COLECCHIA A, COLLI A, CASAZZA G, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study[J]. J Hepatol, 2014, 60(6): 1158-1164. DOI: 10.1016/j.jhep.2014.02.024.
[24]	SALZL P, REIBERGER T, FERLITSCH M, et al. Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index[J]. Ultraschall Med, 2014, 35(6): 528-533. DOI: 10.1055/s-0034-1366506.
[25]	KIM HY, SO YH, KIM W, et al. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices[J]. J Hepatol, 2019, 70(3): 412-422. DOI: 10.1016/j.jhep.2018.10.018.
[26]	JANSEN C, BOGS C, VERLINDEN W, et al. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study[J]. Liver Int, 2017, 37(3): 396-405. DOI: 10.1111/liv.13243.
[27]	ZHU YL, DING H, FU TT, et al. Portal hypertension in hepatitis B-related cirrhosis: Diagnostic accuracy of liver and spleen stiffness by 2-D shear-wave elastography[J]. Hepatol Res, 2019, 49(5): 540-549. DOI: 10.1111/hepr.13306.
[28]	TREBICKA J, GU W, DE LEDINGHEN V, et al. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease[J]. Gut, 2022, 71(2): 402-414. DOI: 10.1136/gutjnl-2020-323419.
[29]	SINGH S, VENKATESH SK, WANG Z, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data[J]. Clin Gastroenterol Hepatol, 2015, 13(3): 440-451. e6. DOI: 10.1016/j.cgh.2014.09.046.
[30]	HUWART L, SEMPOUX C, SALAMEH N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index[J]. Radiology, 2007, 245(2): 458-466. DOI: 10.1148/radiol.2452061673.
[31]	WAGNER M, HECTORS S, BANE O, et al. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results[J]. J Magn Reson Imaging, 2018, 48(4): 1091-1103. DOI: 10.1002/jmri.26026.
[32]	EISENBREY JR, DAVE JK, HALLDORSDOTTIR VG, et al. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient[J]. Radiology, 2013, 268(2): 581-588. DOI: 10.1148/radiol.13121769.
[33]	GUPTA I, EISENBREY JR, MACHADO P, et al. Diagnosing portal hypertension with noninvasive subharmonic pressure estimates from a US contrast agent[J]. Radiology, 2021, 298(1): 104-111. DOI: 10.1148/radiol.2020202677.
[34]	SHARMA S, AGARWAL S, GUNJAN D, et al. Deciding among noninvasive tools for predicting varices needing treatment in chronic liver disease: an analysis of Asian cohort[J]. Am J Gastroenterol, 2020, 115(10): 1650-1656. DOI: 10.14309/ajg.0000000000000722.
[35]	CALVARUSO V, CACCIOLA I, LICATA A, et al. Is transient elastography needed for noninvasive assessment of high-risk varices? The REAL experience[J]. Am J Gastroenterol, 2019, 114(8): 1275-1282. DOI: 10.14309/ajg.0000000000000266.